Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Attention-deficit clinical trials

3 of 3 indexed Attention-deficit trials are currently recruiting.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Attention-deficit: 3 US clinical trials tracked, 3 recruiting.

Attention-deficit is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Children's National Research Institute, running 1 of these trials.

Enrollment posture brief

Registry condition attention-deficit

OPEN 3 | RECR 100% | LATE 0 | EARLY 0 | RANK #5209 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Attention-deficit (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Attention-deficit

Attention-deficit lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Attention-deficit on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Attention-deficit is recruiting above its size-band peers.

    3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Attention-deficit records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Sham transcranial photobiomodulation Device
1 trials
Transcranial photobiomodulation Device
1 trials
Sham app Behavioral
1 trials
Treatment App Behavioral
1 trials
EndeavorRx Device
1 trials

US sites by state

Facility locations filed on Attention-deficit trials. A trial with sites in several states counts in each.

Texas 1 trials
New York 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Attention-deficit page

3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Attention-deficit condition card totals 3 registered trials; most-linked intervention Sham transcranial photobiomodulation; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.